Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 87PZ955YRB

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Subtilisin/kexin type 9 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hyperlipidemias 1 D006949 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298016
FDA SRS 87PZ955YRB